CVS Health Corporation (NYSE:CVS) is one of the stocks Jim Cramer recently shared thoughts on. Cramer discussed the company’s “reinvention,” as he said: “Sadly, this tale of reinvention doesn’t happen ...

Formerly known as AmerisourceBergen until its 2023 rebranding, Cencora (NYSE:COR) is a global pharmaceutical distribution ...

The largest contract paid CVS $200 million from 2020 through 2023, the period when McKee became governor and first campaigned against Foulkes.

A little-known Cigna Group subsidiary that sells generic drugs charges prices that skew higher than many competing suppliers, according to a new analysis that raises questions about the company’s role ...

In essence, West Virginia’s pharmacies cannot sustain operations under the current PBM model. If present trends persist, the ...

Health insurers felt the sting of elevated medical costs yet again in the third quarter, with the congressional debate over the Affordable Care Act subsidies looming large for investors. | Health ...

This morning, when the market was down, my colleagues at Squawk on the Street, David Faber and Carl Quintanilla, were questioning me about whether we just turn to the same old same old growth ...

Trump administration drug deals link U.S. prices to global lows, aiming to cut costs via Pfizer, AstraZeneca, and TrumpRx in 2026.

Concentra®, (NYSE: CON) the nation’s largest provider of occupational health services, today announced the appointment of ...

Barclays analyst Andrew Mok CFA maintained a Buy rating on CVS Health today and set a price target of $87.00. The company’s shares closed yesterday at $78.44. Take advantage of TipRanks Premium at 50% ...

TrumpRx will offer Novo Nordisk's Ozempic and Wegovy through TrumpRx for $350 and Eli Lilly and Company's Zepbound and orforglipron, if approved by the FDA, for $346.